2024 Q2 Form 10-K Financial Statement

#000149315224014823 Filed on April 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $9.841K $26.29K $405.4K
YoY Change -90.77% -74.67% -34.56%
Cost Of Revenue $7.733K $65.62K $313.8K
YoY Change -93.41% -36.3% -15.04%
Gross Profit $2.107K -$39.33K $91.64K
YoY Change -119.68% -5344.0% -63.38%
Gross Profit Margin 21.41% -149.6% 22.6%
Selling, General & Admin $683.3K $794.1K $2.394M
YoY Change 55.15% 34.91% 26.23%
% of Gross Profit 32430.47% 2612.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.84K $10.83K $43.33K
YoY Change -50.18% -50.32%
% of Gross Profit 514.48% 47.28%
Operating Expenses $694.1K $805.0K $2.437M
YoY Change 53.83% 31.88% 28.52%
Operating Profit -$692.0K -$844.3K -$2.345M
YoY Change 49.81% 38.5% -39.06%
Interest Expense -$193.2K -$150.5K -$2.567M
YoY Change -155.77% 75.86% -246.1%
% of Operating Profit
Other Income/Expense, Net $2.600K $28.38K
YoY Change -101.82% -149.91%
Pretax Income -$885.2K -$992.2K -$4.915M
YoY Change 13.12% 18.41% -13.2%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$885.2K -$992.2K -$4.915M
YoY Change 13.12% 18.41% -13.2%
Net Earnings / Revenue -8995.31% -3773.94% -1212.42%
Basic Earnings Per Share $0.00 -$0.04
Diluted Earnings Per Share $0.00 $0.00 -$0.04
COMMON SHARES
Basic Shares Outstanding 1.071B shares 309.8M shares 134.9M shares
Diluted Shares Outstanding 1.982B shares 134.9M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.39K $72.97K $72.97K
YoY Change 77.55% -34.03% -34.03%
Cash & Equivalents $31.39K $72.97K $72.97K
Short-Term Investments
Other Short-Term Assets $12.13K $30.32K $30.32K
YoY Change -36.56% -62.72% -62.72%
Inventory
Prepaid Expenses $12.13K $30.32K
Receivables
Other Receivables
Total Short-Term Assets $43.51K $103.3K $103.3K
YoY Change 18.25% -46.18% -46.18%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $740.5K $740.5K
YoY Change 0.0% 0.0%
Intangibles $509.2K $530.8K
YoY Change -7.55%
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $1.250M $1.271M $1.271M
YoY Change -3.35% -6.84% -6.84%
TOTAL ASSETS
Total Short-Term Assets $43.51K $103.3K $103.3K
Total Long-Term Assets $1.250M $1.271M $1.271M
Total Assets $1.293M $1.375M $1.375M
YoY Change -2.75% -11.69% -11.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.105M $2.679M $2.679M
YoY Change 19.89% 18.24% 18.24%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.822M $2.506M $2.506M
YoY Change 17.19% 13.34% 13.34%
Total Short-Term Liabilities $5.927M $5.185M $5.185M
YoY Change 18.59% 15.82% 15.82%
LONG-TERM LIABILITIES
Long-Term Debt $12.98K $138.3K $138.3K
YoY Change -90.64% -0.55% -0.55%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $12.98K $138.3K $138.3K
YoY Change -90.64% -0.55% -0.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.927M $5.185M $5.185M
Total Long-Term Liabilities $12.98K $138.3K $138.3K
Total Liabilities $5.940M $5.324M $5.324M
YoY Change 15.64% 15.33% 15.33%
SHAREHOLDERS EQUITY
Retained Earnings -$47.24M -$44.45M
YoY Change 9.6% 12.43%
Common Stock $42.59M $40.50M
YoY Change 8.4% 11.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.647M -$3.949M -$3.949M
YoY Change
Total Liabilities & Shareholders Equity $1.293M $1.375M $1.375M
YoY Change -2.75% -11.69% -11.69%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$885.2K -$992.2K -$4.915M
YoY Change 13.12% 18.41% -13.2%
Depreciation, Depletion And Amortization $10.84K $10.83K $43.33K
YoY Change -50.18% -50.32%
Cash From Operating Activities -$257.2K -$415.9K -$1.180M
YoY Change -15.13% -51.34% -38.89%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.00K
YoY Change -4.73%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 266.7K 468.5K 1.142M
YoY Change -12.28% -549.44% -43.34%
NET CHANGE
Cash From Operating Activities -257.2K -415.9K -1.180M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 266.7K 468.5K 1.142M
Net Change In Cash 9.510K 52.54K -37.64K
YoY Change 841.58% 114.01% -207.83%
FREE CASH FLOW
Cash From Operating Activities -$257.2K -$415.9K -$1.180M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$415.9K -$1.180M
YoY Change -422.96% -40.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2023 us-gaap Depreciation
Depreciation
usd
CY2023 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
usd
CY2022 CRCW Loss On Sale Of Property Plant Equipment
LossOnSaleOfPropertyPlantEquipment
usd
CY2023 CRCW Other Income Recovery Of Token Investment
OtherIncomeRecoveryOfTokenInvestment
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
usd
CY2022 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Security12g Title
Security12gTitle
Common Stock, par value $0.001 per share
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
195157 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1071110533 shares
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72970 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110606 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
30317 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
81317 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
103287 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
191923 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
740469 usd
CY2022Q4 us-gaap Goodwill
Goodwill
740469 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
530837 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
574169 usd
CY2023Q4 us-gaap Assets
Assets
1374593 usd
CY2022Q4 us-gaap Assets
Assets
1556561 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2678883 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2265548 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2506443 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2211353 usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
125000 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
313756 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
369313 usd
CY2023 us-gaap Gross Profit
GrossProfit
91641 usd
CY2022 us-gaap Gross Profit
GrossProfit
250225 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1238275 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1864543 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43332 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43332 usd
CY2022 us-gaap Depreciation
Depreciation
87222 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
2437087 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
4099223 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-2345446 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-3848998 usd
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
28375 usd
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
18265 usd
CY2022 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-142728 usd
CY2023 CRCW Loss On Sale Of Property Plant Equipment
LossOnSaleOfPropertyPlantEquipment
31000 usd
CY2022 CRCW Other Income Recovery Of Token Investment
OtherIncomeRecoveryOfTokenInvestment
67600 usd
CY2023 us-gaap Interest Expense
InterestExpense
2567096 usd
CY2022 us-gaap Interest Expense
InterestExpense
1757057 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4915167 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5662918 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4915167 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5662918 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134932832 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
134932832 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23188092 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23188092 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1015817 usd
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
3.28
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26240 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
2060377 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
43750 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1488928 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5662918 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3059440 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3059440 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3059440 usd
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
5.00
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000.00 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000.00 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
410075.05 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2041490.00 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1499376 usd
CY2023 CRCW Stock Issued During Period Value Stock Issued For Accrued Salary
StockIssuedDuringPeriodValueStockIssuedForAccruedSalary
49600 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4915167 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3949065 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3949065 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4915167 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5662918 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
43332 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
130554 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1155480 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
2104126 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2041490 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1488928 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-31000 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
327608 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-51000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-4862 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
413335 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
331748 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1179530 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1930308 usd
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
50000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50000 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
227252 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
761671 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1344146 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2750646 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26240 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1141894 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2015215 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-37636 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34907 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
110606 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
75699 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
72970 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
110606 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72970 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-4915167 usd
CY2023 CRCW Working Capital
WorkingCapital
5082039 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44446602 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_z7kxsoWfEVP2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zDYFOAydaAxc">Use of estimates </span></b>– The preparation of these condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s significant estimates and assumptions include but are not limited to the recoverability and useful lives of long-lived assets, allocation of revenue on software subscriptions, valuation of goodwill from business acquisitions, valuation and recoverability of investments, valuation allowances of deferred taxes, and share- based compensation expenses. Actual results may differ from these estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on the Company’s operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 CRCW Investment In Cryptocurrency
InvestmentInCryptocurrency
0 usd
CY2022Q4 CRCW Investment In Cryptocurrency
InvestmentInCryptocurrency
0 usd
CY2022Q4 CRCW Investment In Noncryptocurrency
InvestmentInNoncryptocurrency
0 usd
CY2022 CRCW Other Income Recovery Of Token Investment
OtherIncomeRecoveryOfTokenInvestment
67600 usd
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
10613000 usd
CY2023 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
expire in 2037
CY2023 us-gaap Marketing Expense
MarketingExpense
26869 usd
CY2022 us-gaap Marketing Expense
MarketingExpense
31777 usd
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zCIWx3YwYhf6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_z4Ji0I6DcFSc">Reclassifications </span>– </b>Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform to the current period presentation. Such reclassifications had no effect on the Company’s financial position, results of operations or cashflows.</span></p>
CY2023Q4 us-gaap Goodwill
Goodwill
740469 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
650000 usd
CY2023 us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustment Intangibles
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
54166 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43332 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43332 usd
CY2023Q4 us-gaap Goodwill
Goodwill
740469 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
574169 usd
CY2022Q4 us-gaap Goodwill
Goodwill
740469 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
617501 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2281349 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.26
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2281349 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.26
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2281349 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.26
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y3M
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.02 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0040 pure
CY2023Q4 CRCW Compensation Expense Related To Restricted Stock Options
CompensationExpenseRelatedToRestrictedStockOptions
186823 usd
CY2022Q4 CRCW Compensation Expense Related To Restricted Stock Options
CompensationExpenseRelatedToRestrictedStockOptions
2086151 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
186823 usd
CY2023 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
17761895 shares
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.01
CY2023 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 usd
CY2022 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 usd

Files In Submission

Name View Source Status
0001493152-24-014823-index-headers.html Edgar Link pending
0001493152-24-014823-index.html Edgar Link pending
0001493152-24-014823.txt Edgar Link pending
0001493152-24-014823-xbrl.zip Edgar Link pending
crcw-20231231.xsd Edgar Link pending
ex10-10.htm Edgar Link pending
ex10-10_001.jpg Edgar Link pending
ex10-10_002.jpg Edgar Link pending
ex10-10_003.jpg Edgar Link pending
ex10-10_004.jpg Edgar Link pending
ex10-10_005.jpg Edgar Link pending
ex10-10_006.jpg Edgar Link pending
ex10-10_007.jpg Edgar Link pending
ex10-10_008.jpg Edgar Link pending
ex10-10_009.jpg Edgar Link pending
ex10-10_010.jpg Edgar Link pending
ex10-10_011.jpg Edgar Link pending
ex10-10_012.jpg Edgar Link pending
ex10-10_013.jpg Edgar Link pending
ex10-10_014.jpg Edgar Link pending
ex10-10_015.jpg Edgar Link pending
ex10-10_016.jpg Edgar Link pending
ex10-10_017.jpg Edgar Link pending
ex10-10_018.jpg Edgar Link pending
ex10-10_019.jpg Edgar Link pending
ex10-10_020.jpg Edgar Link pending
ex10-10_021.jpg Edgar Link pending
ex10-10_022.jpg Edgar Link pending
ex10-10_023.jpg Edgar Link pending
ex10-10_024.jpg Edgar Link pending
ex10-10_025.jpg Edgar Link pending
crcw-20231231_cal.xml Edgar Link unprocessable
crcw-20231231_def.xml Edgar Link unprocessable
crcw-20231231_lab.xml Edgar Link unprocessable
crcw-20231231_pre.xml Edgar Link unprocessable
ex10-11.htm Edgar Link pending
ex10-11_001.jpg Edgar Link pending
ex10-11_002.jpg Edgar Link pending
ex10-11_003.jpg Edgar Link pending
ex10-11_004.jpg Edgar Link pending
ex10-11_005.jpg Edgar Link pending
ex10-11_006.jpg Edgar Link pending
ex10-11_007.jpg Edgar Link pending
ex10-11_008.jpg Edgar Link pending
ex10-11_009.jpg Edgar Link pending
ex10-11_010.jpg Edgar Link pending
ex10-11_011.jpg Edgar Link pending
ex10-11_012.jpg Edgar Link pending
ex10-11_013.jpg Edgar Link pending
ex10-11_014.jpg Edgar Link pending
ex10-11_015.jpg Edgar Link pending
ex10-11_016.jpg Edgar Link pending
ex10-11_017.jpg Edgar Link pending
ex10-11_018.jpg Edgar Link pending
ex10-12.htm Edgar Link pending
ex10-12_001.jpg Edgar Link pending
ex10-12_002.jpg Edgar Link pending
ex10-12_003.jpg Edgar Link pending
ex10-12_004.jpg Edgar Link pending
ex10-12_005.jpg Edgar Link pending
ex10-12_006.jpg Edgar Link pending
ex10-12_007.jpg Edgar Link pending
ex10-12_008.jpg Edgar Link pending
ex10-12_009.jpg Edgar Link pending
ex10-12_010.jpg Edgar Link pending
ex10-12_011.jpg Edgar Link pending
ex10-12_012.jpg Edgar Link pending
ex10-12_013.jpg Edgar Link pending
ex10-12_014.jpg Edgar Link pending
ex10-12_015.jpg Edgar Link pending
ex10-12_016.jpg Edgar Link pending
ex10-12_017.jpg Edgar Link pending
ex10-12_018.jpg Edgar Link pending
ex10-12_019.jpg Edgar Link pending
ex10-12_020.jpg Edgar Link pending
ex10-12_021.jpg Edgar Link pending
ex10-12_022.jpg Edgar Link pending
ex10-12_023.jpg Edgar Link pending
ex10-12_024.jpg Edgar Link pending
ex10-13.htm Edgar Link pending
ex10-13_001.jpg Edgar Link pending
ex10-13_002.jpg Edgar Link pending
ex10-13_003.jpg Edgar Link pending
ex10-13_004.jpg Edgar Link pending
ex10-13_005.jpg Edgar Link pending
ex10-13_006.jpg Edgar Link pending
ex10-13_007.jpg Edgar Link pending
ex10-13_008.jpg Edgar Link pending
ex10-13_009.jpg Edgar Link pending
ex10-13_010.jpg Edgar Link pending
ex10-13_011.jpg Edgar Link pending
ex10-13_012.jpg Edgar Link pending
ex10-13_013.jpg Edgar Link pending
ex10-13_014.jpg Edgar Link pending
ex10-13_015.jpg Edgar Link pending
ex10-13_016.jpg Edgar Link pending
ex10-13_017.jpg Edgar Link pending
ex10-13_018.jpg Edgar Link pending
ex10-13_019.jpg Edgar Link pending
ex10-13_020.jpg Edgar Link pending
ex10-13_021.jpg Edgar Link pending
ex10-13_022.jpg Edgar Link pending
ex10-13_023.jpg Edgar Link pending
ex10-13_024.jpg Edgar Link pending
ex10-13_025.jpg Edgar Link pending
ex10-14.htm Edgar Link pending
ex10-14_001.jpg Edgar Link pending
ex10-14_002.jpg Edgar Link pending
ex10-14_003.jpg Edgar Link pending
ex10-14_004.jpg Edgar Link pending
ex10-14_005.jpg Edgar Link pending
ex10-14_006.jpg Edgar Link pending
ex10-14_007.jpg Edgar Link pending
ex10-14_008.jpg Edgar Link pending
ex10-14_009.jpg Edgar Link pending
ex10-14_010.jpg Edgar Link pending
ex10-14_011.jpg Edgar Link pending
ex10-14_012.jpg Edgar Link pending
ex10-14_013.jpg Edgar Link pending
ex10-14_014.jpg Edgar Link pending
ex10-14_015.jpg Edgar Link pending
ex10-14_016.jpg Edgar Link pending
ex10-14_017.jpg Edgar Link pending
ex10-14_018.jpg Edgar Link pending
ex10-17.htm Edgar Link pending
ex10-17_001.jpg Edgar Link pending
ex10-17_002.jpg Edgar Link pending
ex10-17_003.jpg Edgar Link pending
ex10-17_004.jpg Edgar Link pending
ex10-17_005.jpg Edgar Link pending
ex10-17_006.jpg Edgar Link pending
ex10-17_007.jpg Edgar Link pending
ex10-17_008.jpg Edgar Link pending
ex10-17_009.jpg Edgar Link pending
ex10-17_010.jpg Edgar Link pending
ex10-17_011.jpg Edgar Link pending
ex10-17_012.jpg Edgar Link pending
ex10-17_013.jpg Edgar Link pending
ex10-17_014.jpg Edgar Link pending
ex10-17_015.jpg Edgar Link pending
ex10-17_016.jpg Edgar Link pending
ex10-17_017.jpg Edgar Link pending
ex10-17_018.jpg Edgar Link pending
ex10-17_019.jpg Edgar Link pending
ex10-17_020.jpg Edgar Link pending
ex10-17_021.jpg Edgar Link pending
ex10-17_022.jpg Edgar Link pending
ex10-17_023.jpg Edgar Link pending
ex10-17_024.jpg Edgar Link pending
ex10-18.htm Edgar Link pending
ex10-18_001.jpg Edgar Link pending
ex10-18_002.jpg Edgar Link pending
ex10-18_003.jpg Edgar Link pending
ex10-18_004.jpg Edgar Link pending
ex10-18_005.jpg Edgar Link pending
ex10-18_006.jpg Edgar Link pending
ex10-18_007.jpg Edgar Link pending
ex10-18_008.jpg Edgar Link pending
ex10-18_009.jpg Edgar Link pending
ex10-18_010.jpg Edgar Link pending
ex10-18_011.jpg Edgar Link pending
ex10-18_012.jpg Edgar Link pending
ex10-18_013.jpg Edgar Link pending
ex10-18_014.jpg Edgar Link pending
ex10-18_015.jpg Edgar Link pending
ex10-18_016.jpg Edgar Link pending
ex10-18_017.jpg Edgar Link pending
ex10-18_018.jpg Edgar Link pending
ex10-18_019.jpg Edgar Link pending
ex10-18_020.jpg Edgar Link pending
ex10-18_021.jpg Edgar Link pending
ex10-18_022.jpg Edgar Link pending
ex10-18_023.jpg Edgar Link pending
ex10-18_024.jpg Edgar Link pending
ex10-18_025.jpg Edgar Link pending
ex10-19.htm Edgar Link pending
ex10-19_001.jpg Edgar Link pending
ex10-19_002.jpg Edgar Link pending
ex10-19_003.jpg Edgar Link pending
ex10-19_004.jpg Edgar Link pending
ex10-19_005.jpg Edgar Link pending
ex10-19_006.jpg Edgar Link pending
ex10-19_007.jpg Edgar Link pending
ex10-19_008.jpg Edgar Link pending
ex10-19_009.jpg Edgar Link pending
ex10-19_010.jpg Edgar Link pending
ex10-19_011.jpg Edgar Link pending
ex10-19_012.jpg Edgar Link pending
ex10-19_013.jpg Edgar Link pending
ex10-19_014.jpg Edgar Link pending
ex10-19_015.jpg Edgar Link pending
ex10-19_016.jpg Edgar Link pending
ex10-19_017.jpg Edgar Link pending
ex10-19_018.jpg Edgar Link pending
ex10-20.htm Edgar Link pending
ex10-20_001.jpg Edgar Link pending
ex10-20_002.jpg Edgar Link pending
ex10-20_003.jpg Edgar Link pending
ex10-20_004.jpg Edgar Link pending
ex10-20_005.jpg Edgar Link pending
ex10-20_006.jpg Edgar Link pending
ex10-20_007.jpg Edgar Link pending
ex10-20_008.jpg Edgar Link pending
ex10-20_009.jpg Edgar Link pending
ex10-20_010.jpg Edgar Link pending
ex10-20_011.jpg Edgar Link pending
ex10-20_012.jpg Edgar Link pending
ex10-20_013.jpg Edgar Link pending
ex10-20_014.jpg Edgar Link pending
ex10-20_015.jpg Edgar Link pending
ex10-20_016.jpg Edgar Link pending
ex10-20_017.jpg Edgar Link pending
ex10-20_018.jpg Edgar Link pending
ex10-20_019.jpg Edgar Link pending
ex10-20_020.jpg Edgar Link pending
ex10-20_021.jpg Edgar Link pending
ex10-20_022.jpg Edgar Link pending
ex10-20_023.jpg Edgar Link pending
ex10-20_024.jpg Edgar Link pending
ex10-21.htm Edgar Link pending
ex10-21_001.jpg Edgar Link pending
ex10-21_002.jpg Edgar Link pending
ex10-21_003.jpg Edgar Link pending
ex10-21_004.jpg Edgar Link pending
ex10-21_005.jpg Edgar Link pending
ex10-21_006.jpg Edgar Link pending
ex10-21_007.jpg Edgar Link pending
ex10-21_008.jpg Edgar Link pending
ex10-21_009.jpg Edgar Link pending
ex10-21_010.jpg Edgar Link pending
ex10-21_011.jpg Edgar Link pending
ex10-21_012.jpg Edgar Link pending
ex10-21_013.jpg Edgar Link pending
ex10-21_014.jpg Edgar Link pending
ex10-21_015.jpg Edgar Link pending
ex10-21_016.jpg Edgar Link pending
ex10-21_017.jpg Edgar Link pending
ex10-21_018.jpg Edgar Link pending
ex10-21_019.jpg Edgar Link pending
ex10-21_020.jpg Edgar Link pending
ex10-21_021.jpg Edgar Link pending
ex10-21_022.jpg Edgar Link pending
ex10-21_023.jpg Edgar Link pending
ex10-21_024.jpg Edgar Link pending
ex10-21_025.jpg Edgar Link pending
ex10-22.htm Edgar Link pending
ex10-22_001.jpg Edgar Link pending
ex10-22_002.jpg Edgar Link pending
ex10-22_003.jpg Edgar Link pending
ex10-22_004.jpg Edgar Link pending
ex10-22_005.jpg Edgar Link pending
ex10-22_006.jpg Edgar Link pending
ex10-22_007.jpg Edgar Link pending
ex10-22_008.jpg Edgar Link pending
ex10-22_009.jpg Edgar Link pending
ex10-22_010.jpg Edgar Link pending
ex10-22_011.jpg Edgar Link pending
ex10-22_012.jpg Edgar Link pending
ex10-22_013.jpg Edgar Link pending
ex10-22_014.jpg Edgar Link pending
ex10-22_015.jpg Edgar Link pending
ex10-22_016.jpg Edgar Link pending
ex10-22_017.jpg Edgar Link pending
ex10-22_018.jpg Edgar Link pending
ex10-26.htm Edgar Link pending
ex10-26_001.jpg Edgar Link pending
ex10-26_002.jpg Edgar Link pending
ex10-26_003.jpg Edgar Link pending
ex10-26_004.jpg Edgar Link pending
ex10-26_005.jpg Edgar Link pending
ex10-26_006.jpg Edgar Link pending
ex10-26_007.jpg Edgar Link pending
ex10-26_008.jpg Edgar Link pending
ex10-26_009.jpg Edgar Link pending
ex10-26_010.jpg Edgar Link pending
ex10-26_011.jpg Edgar Link pending
ex10-26_012.jpg Edgar Link pending
ex10-26_013.jpg Edgar Link pending
ex10-26_014.jpg Edgar Link pending
ex10-26_015.jpg Edgar Link pending
ex10-26_016.jpg Edgar Link pending
ex10-26_017.jpg Edgar Link pending
ex10-26_018.jpg Edgar Link pending
ex10-26_019.jpg Edgar Link pending
ex10-26_020.jpg Edgar Link pending
ex10-26_021.jpg Edgar Link pending
ex10-26_022.jpg Edgar Link pending
ex10-26_023.jpg Edgar Link pending
ex10-26_024.jpg Edgar Link pending
ex10-27.htm Edgar Link pending
ex10-27_001.jpg Edgar Link pending
ex10-27_002.jpg Edgar Link pending
ex10-27_003.jpg Edgar Link pending
ex10-27_004.jpg Edgar Link pending
ex10-27_005.jpg Edgar Link pending
ex10-27_006.jpg Edgar Link pending
ex10-27_007.jpg Edgar Link pending
ex10-27_008.jpg Edgar Link pending
ex10-27_009.jpg Edgar Link pending
ex10-27_010.jpg Edgar Link pending
ex10-27_011.jpg Edgar Link pending
ex10-27_012.jpg Edgar Link pending
ex10-27_013.jpg Edgar Link pending
ex10-27_014.jpg Edgar Link pending
ex10-27_015.jpg Edgar Link pending
ex10-27_016.jpg Edgar Link pending
ex10-27_017.jpg Edgar Link pending
ex10-27_018.jpg Edgar Link pending
ex10-27_019.jpg Edgar Link pending
ex10-27_020.jpg Edgar Link pending
ex10-27_021.jpg Edgar Link pending
ex10-27_022.jpg Edgar Link pending
ex10-27_023.jpg Edgar Link pending
ex10-27_024.jpg Edgar Link pending
ex10-27_025.jpg Edgar Link pending
ex10-28.htm Edgar Link pending
ex10-28_001.jpg Edgar Link pending
ex10-28_002.jpg Edgar Link pending
ex10-28_003.jpg Edgar Link pending
ex10-28_004.jpg Edgar Link pending
ex10-28_005.jpg Edgar Link pending
ex10-28_006.jpg Edgar Link pending
ex10-28_007.jpg Edgar Link pending
ex10-28_008.jpg Edgar Link pending
ex10-28_009.jpg Edgar Link pending
ex10-28_010.jpg Edgar Link pending
ex10-28_011.jpg Edgar Link pending
ex10-28_012.jpg Edgar Link pending
ex10-28_013.jpg Edgar Link pending
ex10-28_014.jpg Edgar Link pending
ex10-28_015.jpg Edgar Link pending
ex10-28_016.jpg Edgar Link pending
ex10-28_017.jpg Edgar Link pending
ex10-28_018.jpg Edgar Link pending
ex10-29.htm Edgar Link pending
ex10-29_001.jpg Edgar Link pending
ex10-29_002.jpg Edgar Link pending
ex10-29_003.jpg Edgar Link pending
ex10-30.htm Edgar Link pending
ex10-30_001.jpg Edgar Link pending
ex10-30_002.jpg Edgar Link pending
ex10-30_003.jpg Edgar Link pending
ex10-30_004.jpg Edgar Link pending
ex10-30_005.jpg Edgar Link pending
ex10-30_006.jpg Edgar Link pending
ex10-30_007.jpg Edgar Link pending
ex10-30_008.jpg Edgar Link pending
ex10-30_009.jpg Edgar Link pending
ex10-30_010.jpg Edgar Link pending
ex10-30_011.jpg Edgar Link pending
ex10-30_012.jpg Edgar Link pending
ex10-30_013.jpg Edgar Link pending
ex10-30_014.jpg Edgar Link pending
ex10-30_015.jpg Edgar Link pending
ex10-30_016.jpg Edgar Link pending
ex10-30_017.jpg Edgar Link pending
ex10-30_018.jpg Edgar Link pending
ex10-30_019.jpg Edgar Link pending
ex10-30_020.jpg Edgar Link pending
ex10-30_021.jpg Edgar Link pending
ex10-30_022.jpg Edgar Link pending
ex10-30_023.jpg Edgar Link pending
ex10-30_024.jpg Edgar Link pending
ex10-31.htm Edgar Link pending
ex10-31_001.jpg Edgar Link pending
ex10-31_002.jpg Edgar Link pending
ex10-31_003.jpg Edgar Link pending
ex10-31_004.jpg Edgar Link pending
ex10-31_005.jpg Edgar Link pending
ex10-31_006.jpg Edgar Link pending
ex10-31_007.jpg Edgar Link pending
ex10-31_008.jpg Edgar Link pending
ex10-31_009.jpg Edgar Link pending
ex10-31_010.jpg Edgar Link pending
ex10-31_011.jpg Edgar Link pending
ex10-31_012.jpg Edgar Link pending
ex10-31_013.jpg Edgar Link pending
ex10-31_014.jpg Edgar Link pending
ex10-31_015.jpg Edgar Link pending
ex10-31_016.jpg Edgar Link pending
ex10-31_017.jpg Edgar Link pending
ex10-31_018.jpg Edgar Link pending
ex10-31_019.jpg Edgar Link pending
ex10-31_020.jpg Edgar Link pending
ex10-31_021.jpg Edgar Link pending
ex10-31_022.jpg Edgar Link pending
ex10-31_023.jpg Edgar Link pending
ex10-31_024.jpg Edgar Link pending
ex10-31_025.jpg Edgar Link pending
ex10-32.htm Edgar Link pending
ex10-32_001.jpg Edgar Link pending
ex10-32_002.jpg Edgar Link pending
ex10-32_003.jpg Edgar Link pending
ex10-32_004.jpg Edgar Link pending
ex10-32_005.jpg Edgar Link pending
ex10-32_006.jpg Edgar Link pending
ex10-32_007.jpg Edgar Link pending
ex10-32_008.jpg Edgar Link pending
ex10-32_009.jpg Edgar Link pending
ex10-32_010.jpg Edgar Link pending
ex10-32_011.jpg Edgar Link pending
ex10-32_012.jpg Edgar Link pending
ex10-32_013.jpg Edgar Link pending
ex10-32_014.jpg Edgar Link pending
ex10-32_015.jpg Edgar Link pending
ex10-32_016.jpg Edgar Link pending
ex10-32_017.jpg Edgar Link pending
ex10-32_018.jpg Edgar Link pending
ex10-9.htm Edgar Link pending
ex10-9_001.jpg Edgar Link pending
ex10-9_002.jpg Edgar Link pending
ex10-9_003.jpg Edgar Link pending
ex10-9_004.jpg Edgar Link pending
ex10-9_005.jpg Edgar Link pending
ex10-9_006.jpg Edgar Link pending
ex10-9_007.jpg Edgar Link pending
ex10-9_008.jpg Edgar Link pending
ex10-9_009.jpg Edgar Link pending
ex10-9_010.jpg Edgar Link pending
ex10-9_011.jpg Edgar Link pending
ex10-9_012.jpg Edgar Link pending
ex10-9_013.jpg Edgar Link pending
ex10-9_014.jpg Edgar Link pending
ex10-9_015.jpg Edgar Link pending
ex10-9_016.jpg Edgar Link pending
ex10-9_017.jpg Edgar Link pending
ex10-9_018.jpg Edgar Link pending
ex10-9_019.jpg Edgar Link pending
ex10-9_020.jpg Edgar Link pending
ex10-9_021.jpg Edgar Link pending
ex10-9_022.jpg Edgar Link pending
ex10-9_023.jpg Edgar Link pending
ex10-9_024.jpg Edgar Link pending
ex21-1.htm Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
form10-k_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable